nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—CYP2C19—Sorafenib—liver cancer	0.132	0.19	CbGbCtD
Desloratadine—CYP1A2—Sorafenib—liver cancer	0.122	0.175	CbGbCtD
Desloratadine—CYP2C9—Sorafenib—liver cancer	0.11	0.158	CbGbCtD
Desloratadine—ABCB1—Sorafenib—liver cancer	0.106	0.153	CbGbCtD
Desloratadine—CYP2D6—Sorafenib—liver cancer	0.1	0.144	CbGbCtD
Desloratadine—ABCB1—Doxorubicin—liver cancer	0.0646	0.0929	CbGbCtD
Desloratadine—CYP2D6—Doxorubicin—liver cancer	0.0609	0.0875	CbGbCtD
Desloratadine—Rhinorrhoea—Sorafenib—liver cancer	0.00541	0.0351	CcSEcCtD
Desloratadine—Blood bilirubin increased—Sorafenib—liver cancer	0.00463	0.0301	CcSEcCtD
Desloratadine—Mood swings—Sorafenib—liver cancer	0.00301	0.0196	CcSEcCtD
Desloratadine—Breast disorder—Sorafenib—liver cancer	0.00287	0.0187	CcSEcCtD
Desloratadine—Nasopharyngitis—Sorafenib—liver cancer	0.00284	0.0185	CcSEcCtD
Desloratadine—Infestation—Sorafenib—liver cancer	0.00245	0.0159	CcSEcCtD
Desloratadine—Infestation NOS—Sorafenib—liver cancer	0.00245	0.0159	CcSEcCtD
Desloratadine—Hepatobiliary disease—Sorafenib—liver cancer	0.00232	0.0151	CcSEcCtD
Desloratadine—Epistaxis—Sorafenib—liver cancer	0.00231	0.015	CcSEcCtD
Desloratadine—Connective tissue disorder—Sorafenib—liver cancer	0.00216	0.014	CcSEcCtD
Desloratadine—Otitis media—Epirubicin—liver cancer	0.00208	0.0135	CcSEcCtD
Desloratadine—Cardiac disorder—Sorafenib—liver cancer	0.00204	0.0133	CcSEcCtD
Desloratadine—Mental disorder—Sorafenib—liver cancer	0.00193	0.0125	CcSEcCtD
Desloratadine—Otitis media—Doxorubicin—liver cancer	0.00192	0.0125	CcSEcCtD
Desloratadine—Erythema—Sorafenib—liver cancer	0.00192	0.0124	CcSEcCtD
Desloratadine—Viral infection—Epirubicin—liver cancer	0.00179	0.0116	CcSEcCtD
Desloratadine—Angioedema—Sorafenib—liver cancer	0.00175	0.0114	CcSEcCtD
Desloratadine—Dyskinesia—Epirubicin—liver cancer	0.00172	0.0112	CcSEcCtD
Desloratadine—Blood bilirubin increased—Epirubicin—liver cancer	0.00171	0.0111	CcSEcCtD
Desloratadine—Cough—Sorafenib—liver cancer	0.00167	0.0109	CcSEcCtD
Desloratadine—Viral infection—Doxorubicin—liver cancer	0.00166	0.0108	CcSEcCtD
Desloratadine—Myalgia—Sorafenib—liver cancer	0.00163	0.0106	CcSEcCtD
Desloratadine—Dry mouth—Sorafenib—liver cancer	0.0016	0.0104	CcSEcCtD
Desloratadine—Dyskinesia—Doxorubicin—liver cancer	0.00159	0.0104	CcSEcCtD
Desloratadine—Blood bilirubin increased—Doxorubicin—liver cancer	0.00158	0.0103	CcSEcCtD
Desloratadine—Anaphylactic shock—Sorafenib—liver cancer	0.00156	0.0102	CcSEcCtD
Desloratadine—Infection—Sorafenib—liver cancer	0.00155	0.0101	CcSEcCtD
Desloratadine—Nervous system disorder—Sorafenib—liver cancer	0.00153	0.00996	CcSEcCtD
Desloratadine—Anorexia—Sorafenib—liver cancer	0.00149	0.00968	CcSEcCtD
Desloratadine—Rash maculo-papular—Epirubicin—liver cancer	0.00147	0.00956	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00142	0.00925	CcSEcCtD
Desloratadine—Dyspnoea—Sorafenib—liver cancer	0.00139	0.00905	CcSEcCtD
Desloratadine—Dyspepsia—Sorafenib—liver cancer	0.00138	0.00894	CcSEcCtD
Desloratadine—Rash maculo-papular—Doxorubicin—liver cancer	0.00136	0.00884	CcSEcCtD
Desloratadine—Decreased appetite—Sorafenib—liver cancer	0.00136	0.00883	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00135	0.00876	CcSEcCtD
Desloratadine—Fatigue—Sorafenib—liver cancer	0.00135	0.00875	CcSEcCtD
Desloratadine—Gastrointestinal pain—Sorafenib—liver cancer	0.00128	0.0083	CcSEcCtD
Desloratadine—Increased appetite—Epirubicin—liver cancer	0.00125	0.00812	CcSEcCtD
Desloratadine—Urticaria—Sorafenib—liver cancer	0.00124	0.00806	CcSEcCtD
Desloratadine—Body temperature increased—Sorafenib—liver cancer	0.00124	0.00803	CcSEcCtD
Desloratadine—Abdominal pain—Sorafenib—liver cancer	0.00124	0.00803	CcSEcCtD
Desloratadine—Increased appetite—Doxorubicin—liver cancer	0.00116	0.00752	CcSEcCtD
Desloratadine—Affect lability—Epirubicin—liver cancer	0.00116	0.00751	CcSEcCtD
Desloratadine—Hypersensitivity—Sorafenib—liver cancer	0.00115	0.00748	CcSEcCtD
Desloratadine—Asthenia—Sorafenib—liver cancer	0.00112	0.00728	CcSEcCtD
Desloratadine—Mood swings—Epirubicin—liver cancer	0.00111	0.00723	CcSEcCtD
Desloratadine—Pruritus—Sorafenib—liver cancer	0.00111	0.00718	CcSEcCtD
Desloratadine—Affect lability—Doxorubicin—liver cancer	0.00107	0.00695	CcSEcCtD
Desloratadine—Diarrhoea—Sorafenib—liver cancer	0.00107	0.00695	CcSEcCtD
Desloratadine—Breast disorder—Epirubicin—liver cancer	0.00106	0.0069	CcSEcCtD
Desloratadine—Nasopharyngitis—Epirubicin—liver cancer	0.00105	0.00683	CcSEcCtD
Desloratadine—Dizziness—Sorafenib—liver cancer	0.00103	0.00671	CcSEcCtD
Desloratadine—Mood swings—Doxorubicin—liver cancer	0.00103	0.00669	CcSEcCtD
Desloratadine—Vomiting—Sorafenib—liver cancer	0.000994	0.00645	CcSEcCtD
Desloratadine—Rash—Sorafenib—liver cancer	0.000986	0.0064	CcSEcCtD
Desloratadine—Dermatitis—Sorafenib—liver cancer	0.000985	0.0064	CcSEcCtD
Desloratadine—Breast disorder—Doxorubicin—liver cancer	0.000983	0.00638	CcSEcCtD
Desloratadine—Headache—Sorafenib—liver cancer	0.000979	0.00636	CcSEcCtD
Desloratadine—Bronchitis—Epirubicin—liver cancer	0.000977	0.00635	CcSEcCtD
Desloratadine—Nasopharyngitis—Doxorubicin—liver cancer	0.000973	0.00632	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Epirubicin—liver cancer	0.000944	0.00613	CcSEcCtD
Desloratadine—Nausea—Sorafenib—liver cancer	0.000929	0.00603	CcSEcCtD
Desloratadine—Infestation—Epirubicin—liver cancer	0.000906	0.00588	CcSEcCtD
Desloratadine—Infestation NOS—Epirubicin—liver cancer	0.000906	0.00588	CcSEcCtD
Desloratadine—Bronchitis—Doxorubicin—liver cancer	0.000904	0.00587	CcSEcCtD
Desloratadine—Urinary tract infection—Epirubicin—liver cancer	0.000881	0.00572	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000874	0.00567	CcSEcCtD
Desloratadine—Hepatobiliary disease—Epirubicin—liver cancer	0.000857	0.00556	CcSEcCtD
Desloratadine—Epistaxis—Epirubicin—liver cancer	0.000855	0.00555	CcSEcCtD
Desloratadine—Infestation NOS—Doxorubicin—liver cancer	0.000838	0.00544	CcSEcCtD
Desloratadine—Infestation—Doxorubicin—liver cancer	0.000838	0.00544	CcSEcCtD
Desloratadine—Urinary tract infection—Doxorubicin—liver cancer	0.000815	0.00529	CcSEcCtD
Desloratadine—Hepatitis—Epirubicin—liver cancer	0.000813	0.00528	CcSEcCtD
Desloratadine—Pharyngitis—Epirubicin—liver cancer	0.000807	0.00524	CcSEcCtD
Desloratadine—Connective tissue disorder—Epirubicin—liver cancer	0.000799	0.00519	CcSEcCtD
Desloratadine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000793	0.00515	CcSEcCtD
Desloratadine—Epistaxis—Doxorubicin—liver cancer	0.000791	0.00513	CcSEcCtD
Desloratadine—Cardiac disorder—Epirubicin—liver cancer	0.000755	0.0049	CcSEcCtD
Desloratadine—Hepatitis—Doxorubicin—liver cancer	0.000753	0.00489	CcSEcCtD
Desloratadine—Pharyngitis—Doxorubicin—liver cancer	0.000747	0.00485	CcSEcCtD
Desloratadine—Connective tissue disorder—Doxorubicin—liver cancer	0.000739	0.0048	CcSEcCtD
Desloratadine—Mental disorder—Epirubicin—liver cancer	0.000713	0.00463	CcSEcCtD
Desloratadine—Erythema—Epirubicin—liver cancer	0.000708	0.0046	CcSEcCtD
Desloratadine—Cardiac disorder—Doxorubicin—liver cancer	0.000698	0.00453	CcSEcCtD
Desloratadine—Mental disorder—Doxorubicin—liver cancer	0.000659	0.00428	CcSEcCtD
Desloratadine—Erythema—Doxorubicin—liver cancer	0.000655	0.00425	CcSEcCtD
Desloratadine—Agitation—Epirubicin—liver cancer	0.000651	0.00422	CcSEcCtD
Desloratadine—Palpitations—Epirubicin—liver cancer	0.000626	0.00406	CcSEcCtD
Desloratadine—Cough—Epirubicin—liver cancer	0.000618	0.00401	CcSEcCtD
Desloratadine—Convulsion—Epirubicin—liver cancer	0.000613	0.00398	CcSEcCtD
Desloratadine—Myalgia—Epirubicin—liver cancer	0.000603	0.00391	CcSEcCtD
Desloratadine—Agitation—Doxorubicin—liver cancer	0.000602	0.00391	CcSEcCtD
Desloratadine—Dry mouth—Epirubicin—liver cancer	0.000589	0.00383	CcSEcCtD
Desloratadine—Palpitations—Doxorubicin—liver cancer	0.000579	0.00376	CcSEcCtD
Desloratadine—Anaphylactic shock—Epirubicin—liver cancer	0.000578	0.00375	CcSEcCtD
Desloratadine—Oedema—Epirubicin—liver cancer	0.000578	0.00375	CcSEcCtD
Desloratadine—Infection—Epirubicin—liver cancer	0.000574	0.00373	CcSEcCtD
Desloratadine—Cough—Doxorubicin—liver cancer	0.000572	0.00371	CcSEcCtD
Desloratadine—Convulsion—Doxorubicin—liver cancer	0.000568	0.00369	CcSEcCtD
Desloratadine—Nervous system disorder—Epirubicin—liver cancer	0.000567	0.00368	CcSEcCtD
Desloratadine—Tachycardia—Epirubicin—liver cancer	0.000564	0.00366	CcSEcCtD
Desloratadine—Myalgia—Doxorubicin—liver cancer	0.000558	0.00362	CcSEcCtD
Desloratadine—Anorexia—Epirubicin—liver cancer	0.000551	0.00358	CcSEcCtD
Desloratadine—Dry mouth—Doxorubicin—liver cancer	0.000545	0.00354	CcSEcCtD
Desloratadine—Oedema—Doxorubicin—liver cancer	0.000535	0.00347	CcSEcCtD
Desloratadine—Anaphylactic shock—Doxorubicin—liver cancer	0.000535	0.00347	CcSEcCtD
Desloratadine—Infection—Doxorubicin—liver cancer	0.000531	0.00345	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000526	0.00342	CcSEcCtD
Desloratadine—Nervous system disorder—Doxorubicin—liver cancer	0.000524	0.0034	CcSEcCtD
Desloratadine—Insomnia—Epirubicin—liver cancer	0.000523	0.00339	CcSEcCtD
Desloratadine—Tachycardia—Doxorubicin—liver cancer	0.000522	0.00339	CcSEcCtD
Desloratadine—Dyspnoea—Epirubicin—liver cancer	0.000515	0.00334	CcSEcCtD
Desloratadine—Somnolence—Epirubicin—liver cancer	0.000514	0.00334	CcSEcCtD
Desloratadine—Anorexia—Doxorubicin—liver cancer	0.00051	0.00331	CcSEcCtD
Desloratadine—Dyspepsia—Epirubicin—liver cancer	0.000509	0.0033	CcSEcCtD
Desloratadine—Decreased appetite—Epirubicin—liver cancer	0.000502	0.00326	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000499	0.00324	CcSEcCtD
Desloratadine—Fatigue—Epirubicin—liver cancer	0.000498	0.00323	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000487	0.00316	CcSEcCtD
Desloratadine—Insomnia—Doxorubicin—liver cancer	0.000484	0.00314	CcSEcCtD
Desloratadine—Dyspnoea—Doxorubicin—liver cancer	0.000477	0.0031	CcSEcCtD
Desloratadine—Somnolence—Doxorubicin—liver cancer	0.000475	0.00309	CcSEcCtD
Desloratadine—Gastrointestinal pain—Epirubicin—liver cancer	0.000472	0.00307	CcSEcCtD
Desloratadine—Dyspepsia—Doxorubicin—liver cancer	0.000471	0.00306	CcSEcCtD
Desloratadine—Decreased appetite—Doxorubicin—liver cancer	0.000465	0.00302	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000462	0.003	CcSEcCtD
Desloratadine—Fatigue—Doxorubicin—liver cancer	0.000461	0.00299	CcSEcCtD
Desloratadine—Urticaria—Epirubicin—liver cancer	0.000459	0.00298	CcSEcCtD
Desloratadine—Body temperature increased—Epirubicin—liver cancer	0.000457	0.00297	CcSEcCtD
Desloratadine—Abdominal pain—Epirubicin—liver cancer	0.000457	0.00297	CcSEcCtD
Desloratadine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000437	0.00284	CcSEcCtD
Desloratadine—Hypersensitivity—Epirubicin—liver cancer	0.000426	0.00276	CcSEcCtD
Desloratadine—Urticaria—Doxorubicin—liver cancer	0.000425	0.00276	CcSEcCtD
Desloratadine—Abdominal pain—Doxorubicin—liver cancer	0.000423	0.00274	CcSEcCtD
Desloratadine—Body temperature increased—Doxorubicin—liver cancer	0.000423	0.00274	CcSEcCtD
Desloratadine—Asthenia—Epirubicin—liver cancer	0.000415	0.00269	CcSEcCtD
Desloratadine—Pruritus—Epirubicin—liver cancer	0.000409	0.00265	CcSEcCtD
Desloratadine—Diarrhoea—Epirubicin—liver cancer	0.000395	0.00257	CcSEcCtD
Desloratadine—Hypersensitivity—Doxorubicin—liver cancer	0.000394	0.00256	CcSEcCtD
Desloratadine—Asthenia—Doxorubicin—liver cancer	0.000384	0.00249	CcSEcCtD
Desloratadine—Dizziness—Epirubicin—liver cancer	0.000382	0.00248	CcSEcCtD
Desloratadine—Pruritus—Doxorubicin—liver cancer	0.000378	0.00246	CcSEcCtD
Desloratadine—Vomiting—Epirubicin—liver cancer	0.000367	0.00239	CcSEcCtD
Desloratadine—Diarrhoea—Doxorubicin—liver cancer	0.000366	0.00238	CcSEcCtD
Desloratadine—Rash—Epirubicin—liver cancer	0.000364	0.00237	CcSEcCtD
Desloratadine—Dermatitis—Epirubicin—liver cancer	0.000364	0.00236	CcSEcCtD
Desloratadine—Headache—Epirubicin—liver cancer	0.000362	0.00235	CcSEcCtD
Desloratadine—Dizziness—Doxorubicin—liver cancer	0.000354	0.0023	CcSEcCtD
Desloratadine—Nausea—Epirubicin—liver cancer	0.000343	0.00223	CcSEcCtD
Desloratadine—Vomiting—Doxorubicin—liver cancer	0.00034	0.00221	CcSEcCtD
Desloratadine—Rash—Doxorubicin—liver cancer	0.000337	0.00219	CcSEcCtD
Desloratadine—Dermatitis—Doxorubicin—liver cancer	0.000337	0.00219	CcSEcCtD
Desloratadine—Headache—Doxorubicin—liver cancer	0.000335	0.00217	CcSEcCtD
Desloratadine—Nausea—Doxorubicin—liver cancer	0.000318	0.00206	CcSEcCtD
Desloratadine—HRH1—Signaling by GPCR—PRKCE—liver cancer	6.51e-05	0.000433	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	6.46e-05	0.00043	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NR1H4—liver cancer	6.44e-05	0.000428	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CSF2—liver cancer	6.34e-05	0.000422	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTA3—liver cancer	6.33e-05	0.000421	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NR1H4—liver cancer	6.29e-05	0.000418	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	6.2e-05	0.000412	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	6.18e-05	0.000411	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTA3—liver cancer	6.18e-05	0.000411	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CPT1B—liver cancer	6.14e-05	0.000409	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GLUL—liver cancer	6.14e-05	0.000409	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GLUL—liver cancer	6.09e-05	0.000405	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CPT1B—liver cancer	6.09e-05	0.000405	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	5.95e-05	0.000396	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NR1H4—liver cancer	5.92e-05	0.000394	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NR1H4—liver cancer	5.87e-05	0.000391	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTA3—liver cancer	5.82e-05	0.000387	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTA4—liver cancer	5.79e-05	0.000385	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTA3—liver cancer	5.77e-05	0.000384	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CSF2—liver cancer	5.76e-05	0.000383	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	5.7e-05	0.000379	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	5.69e-05	0.000378	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.66e-05	0.000377	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTA4—liver cancer	5.65e-05	0.000376	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTA2—liver cancer	5.64e-05	0.000375	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	5.64e-05	0.000375	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTA2—liver cancer	5.51e-05	0.000366	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTA1—liver cancer	5.45e-05	0.000362	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NAT2—liver cancer	5.38e-05	0.000358	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTA4—liver cancer	5.33e-05	0.000354	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTA1—liver cancer	5.31e-05	0.000354	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	5.31e-05	0.000353	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ADAM17—liver cancer	5.28e-05	0.000351	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTA4—liver cancer	5.28e-05	0.000351	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	5.27e-05	0.000351	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NAT2—liver cancer	5.26e-05	0.00035	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CPT1B—liver cancer	5.2e-05	0.000346	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GLUL—liver cancer	5.2e-05	0.000346	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTA2—liver cancer	5.19e-05	0.000345	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.18e-05	0.000344	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ALDOB—liver cancer	5.16e-05	0.000343	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.16e-05	0.000343	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTA2—liver cancer	5.15e-05	0.000342	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ALDOB—liver cancer	5.04e-05	0.000335	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NR1H4—liver cancer	5.02e-05	0.000334	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTA1—liver cancer	5.01e-05	0.000333	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—F2—liver cancer	4.98e-05	0.000331	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PSMD10—liver cancer	4.97e-05	0.00033	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PSMA4—liver cancer	4.97e-05	0.00033	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTA1—liver cancer	4.96e-05	0.00033	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NAT2—liver cancer	4.95e-05	0.000329	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTA3—liver cancer	4.93e-05	0.000328	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CRABP1—liver cancer	4.92e-05	0.000328	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NAT2—liver cancer	4.91e-05	0.000327	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	4.84e-05	0.000322	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CRABP1—liver cancer	4.81e-05	0.00032	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	4.8e-05	0.00032	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CG—liver cancer	4.76e-05	0.000317	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ALDOB—liver cancer	4.75e-05	0.000316	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.72e-05	0.000314	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ALDOB—liver cancer	4.71e-05	0.000313	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	4.68e-05	0.000312	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CRABP1—liver cancer	4.53e-05	0.000301	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—F2—liver cancer	4.52e-05	0.000301	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTA4—liver cancer	4.51e-05	0.0003	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CRABP1—liver cancer	4.49e-05	0.000299	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.43e-05	0.000295	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	4.41e-05	0.000293	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTA2—liver cancer	4.4e-05	0.000293	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CG—liver cancer	4.33e-05	0.000288	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—HPGDS—liver cancer	4.3e-05	0.000286	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.28e-05	0.000285	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTA1—liver cancer	4.24e-05	0.000282	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—HPGDS—liver cancer	4.2e-05	0.000279	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NAT2—liver cancer	4.2e-05	0.000279	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CD—liver cancer	4.19e-05	0.000279	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.04e-05	0.000269	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.03e-05	0.000268	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALDOB—liver cancer	4.02e-05	0.000268	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—HPGDS—liver cancer	3.96e-05	0.000263	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.95e-05	0.000263	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—HPGDS—liver cancer	3.92e-05	0.000261	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.9e-05	0.00026	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.9e-05	0.000259	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.85e-05	0.000256	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PRKCE—liver cancer	3.85e-05	0.000256	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CRABP1—liver cancer	3.84e-05	0.000255	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PSMD10—liver cancer	3.84e-05	0.000255	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PSMA4—liver cancer	3.84e-05	0.000255	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CD—liver cancer	3.8e-05	0.000253	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PSMD10—liver cancer	3.74e-05	0.000249	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PSMA4—liver cancer	3.74e-05	0.000249	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GOT2—liver cancer	3.73e-05	0.000248	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CB—liver cancer	3.65e-05	0.000243	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IGF2—liver cancer	3.65e-05	0.000242	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GOT2—liver cancer	3.64e-05	0.000242	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	3.57e-05	0.000238	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.55e-05	0.000236	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PSMA4—liver cancer	3.53e-05	0.000235	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PSMD10—liver cancer	3.53e-05	0.000235	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP2E1—liver cancer	3.51e-05	0.000233	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.51e-05	0.000233	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PSMA4—liver cancer	3.5e-05	0.000233	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PSMD10—liver cancer	3.5e-05	0.000233	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.45e-05	0.00023	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GOT2—liver cancer	3.43e-05	0.000228	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP2E1—liver cancer	3.42e-05	0.000228	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CSF2—liver cancer	3.4e-05	0.000226	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GOT2—liver cancer	3.4e-05	0.000226	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.4e-05	0.000226	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—RAF1—liver cancer	3.4e-05	0.000226	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—H2AFX—liver cancer	3.35e-05	0.000223	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HPGDS—liver cancer	3.35e-05	0.000223	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—IL2—liver cancer	3.35e-05	0.000223	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.33e-05	0.000222	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CB—liver cancer	3.32e-05	0.000221	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYCS—liver cancer	3.28e-05	0.000218	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	3.23e-05	0.000215	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP2E1—liver cancer	3.23e-05	0.000215	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GGT1—liver cancer	3.22e-05	0.000214	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GOT1—liver cancer	3.22e-05	0.000214	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYCS—liver cancer	3.2e-05	0.000213	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP2E1—liver cancer	3.2e-05	0.000213	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GGT1—liver cancer	3.14e-05	0.000209	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GOT1—liver cancer	3.14e-05	0.000209	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.1e-05	0.000206	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL2—liver cancer	3.04e-05	0.000203	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.04e-05	0.000202	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TERT—liver cancer	3.03e-05	0.000202	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYCS—liver cancer	3.02e-05	0.000201	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	3e-05	0.000199	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYCS—liver cancer	2.99e-05	0.000199	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PSMD10—liver cancer	2.99e-05	0.000199	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PSMA4—liver cancer	2.99e-05	0.000199	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GOT1—liver cancer	2.96e-05	0.000197	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GGT1—liver cancer	2.96e-05	0.000197	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GGT1—liver cancer	2.94e-05	0.000195	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GOT1—liver cancer	2.94e-05	0.000195	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GOT2—liver cancer	2.91e-05	0.000193	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTP1—liver cancer	2.89e-05	0.000193	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—HMOX1—liver cancer	2.85e-05	0.00019	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTP1—liver cancer	2.82e-05	0.000188	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—HMOX1—liver cancer	2.79e-05	0.000185	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KDR—liver cancer	2.77e-05	0.000185	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK14—liver cancer	2.76e-05	0.000183	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP2E1—liver cancer	2.73e-05	0.000182	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ESR1—liver cancer	2.7e-05	0.00018	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—F2—liver cancer	2.67e-05	0.000178	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTP1—liver cancer	2.66e-05	0.000177	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTM1—liver cancer	2.66e-05	0.000177	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.65e-05	0.000176	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTP1—liver cancer	2.64e-05	0.000176	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—HMOX1—liver cancer	2.62e-05	0.000175	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—HMOX1—liver cancer	2.6e-05	0.000173	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTM1—liver cancer	2.6e-05	0.000173	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYCS—liver cancer	2.56e-05	0.00017	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CG—liver cancer	2.56e-05	0.00017	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APC—liver cancer	2.56e-05	0.00017	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP1A1—liver cancer	2.52e-05	0.000168	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GGT1—liver cancer	2.51e-05	0.000167	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GOT1—liver cancer	2.51e-05	0.000167	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP1A1—liver cancer	2.46e-05	0.000164	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTM1—liver cancer	2.45e-05	0.000163	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTM1—liver cancer	2.42e-05	0.000161	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—BRAF—liver cancer	2.4e-05	0.00016	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—MTHFR—liver cancer	2.35e-05	0.000156	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP1A1—liver cancer	2.32e-05	0.000154	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PPARA—liver cancer	2.31e-05	0.000153	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP1A1—liver cancer	2.3e-05	0.000153	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—MTHFR—liver cancer	2.29e-05	0.000153	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTP1—liver cancer	2.25e-05	0.00015	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PPARA—liver cancer	2.25e-05	0.00015	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CD—liver cancer	2.25e-05	0.000149	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CA—liver cancer	2.23e-05	0.000148	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HMOX1—liver cancer	2.22e-05	0.000148	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SERPINE1—liver cancer	2.22e-05	0.000148	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—KRAS—liver cancer	2.2e-05	0.000146	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—MTHFR—liver cancer	2.16e-05	0.000144	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—MTHFR—liver cancer	2.14e-05	0.000143	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PPARA—liver cancer	2.12e-05	0.000141	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PPARA—liver cancer	2.1e-05	0.00014	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTM1—liver cancer	2.07e-05	0.000138	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.07e-05	0.000138	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CA—liver cancer	2.02e-05	0.000134	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—RAF1—liver cancer	2.01e-05	0.000133	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CG—liver cancer	1.97e-05	0.000131	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP1A1—liver cancer	1.96e-05	0.000131	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MTOR—liver cancer	1.96e-05	0.00013	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CB—liver cancer	1.96e-05	0.00013	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CG—liver cancer	1.93e-05	0.000128	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PPARG—liver cancer	1.91e-05	0.000127	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.89e-05	0.000126	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—HRAS—liver cancer	1.87e-05	0.000124	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PPARG—liver cancer	1.86e-05	0.000124	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN1B—liver cancer	1.84e-05	0.000122	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—MTHFR—liver cancer	1.83e-05	0.000122	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—AKT1—liver cancer	1.82e-05	0.000121	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CG—liver cancer	1.82e-05	0.000121	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CASP3—liver cancer	1.8e-05	0.00012	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CG—liver cancer	1.8e-05	0.00012	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL2—liver cancer	1.8e-05	0.00012	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PPARA—liver cancer	1.8e-05	0.00012	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL6—liver cancer	1.79e-05	0.000119	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCND1—liver cancer	1.75e-05	0.000117	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PPARG—liver cancer	1.75e-05	0.000117	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—JUN—liver cancer	1.75e-05	0.000116	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PPARG—liver cancer	1.74e-05	0.000116	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CTNNB1—liver cancer	1.74e-05	0.000116	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CD—liver cancer	1.74e-05	0.000115	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ALB—liver cancer	1.71e-05	0.000114	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MMP9—liver cancer	1.7e-05	0.000113	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN1A—liver cancer	1.7e-05	0.000113	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CD—liver cancer	1.69e-05	0.000113	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ALB—liver cancer	1.67e-05	0.000111	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK8—liver cancer	1.66e-05	0.00011	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—AKT1—liver cancer	1.65e-05	0.00011	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.61e-05	0.000107	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CD—liver cancer	1.6e-05	0.000106	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CD—liver cancer	1.58e-05	0.000105	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ALB—liver cancer	1.58e-05	0.000105	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ALB—liver cancer	1.56e-05	0.000104	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CG—liver cancer	1.54e-05	0.000102	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—VEGFA—liver cancer	1.53e-05	0.000102	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT3—liver cancer	1.51e-05	0.000101	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CB—liver cancer	1.51e-05	0.000101	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PPARG—liver cancer	1.48e-05	9.88e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CB—liver cancer	1.48e-05	9.82e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MYC—liver cancer	1.41e-05	9.36e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TGFB1—liver cancer	1.4e-05	9.33e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CB—liver cancer	1.39e-05	9.26e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CB—liver cancer	1.38e-05	9.18e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CD—liver cancer	1.35e-05	9e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALB—liver cancer	1.34e-05	8.88e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KRAS—liver cancer	1.3e-05	8.65e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CA—liver cancer	1.19e-05	7.94e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CB—liver cancer	1.18e-05	7.84e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TP53—liver cancer	1.16e-05	7.68e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HRAS—liver cancer	1.1e-05	7.35e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL6—liver cancer	1.06e-05	7.03e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AKT1—liver cancer	9.75e-06	6.49e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CA—liver cancer	9.22e-06	6.14e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CA—liver cancer	9e-06	5.99e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CA—liver cancer	8.48e-06	5.64e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CA—liver cancer	8.41e-06	5.59e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—AKT1—liver cancer	7.53e-06	5.01e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—AKT1—liver cancer	7.35e-06	4.89e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CA—liver cancer	7.19e-06	4.78e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—AKT1—liver cancer	6.93e-06	4.61e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—AKT1—liver cancer	6.87e-06	4.57e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—AKT1—liver cancer	5.87e-06	3.91e-05	CbGpPWpGaD
